Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human”

1,164 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,164
Index total 30,257
Page 8 / 49

Quick answer

This filtered view shows 1,164 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,164 results for “The United States of America, as represented by the Secretary, Department of Health and Human” · 30,257 patents in full index Clear search

  1. US 11591372

    Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted

  2. US 11583556

    Modified cells and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  3. US 11584736

    Heterocyclic P2Y14 receptor antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted

  4. US 11578103

    Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted

  5. US 11555021

    Fatty acid derivatives and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  6. US 11549125

    Closed-ended, linear, duplex adenoassociated virus DNA, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  7. US 11535651

    Hepatitis B nanoparticle-based vaccine for influenza virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  8. US 11535870

    Adeno-associated virus vectors encoding modified G6PC and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  9. US 11529312

    Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  10. US 11510998

    Gene therapy for combined methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocystinuria, cobalamin C type, and deficiency of MMACHC

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

  11. US 11512313

    Functionally-interdependent shape switching nucleic acid nanoparticles

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted

  12. US 11491187

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted

  13. US 11491123

    Pharmaceutical compositions with antiflaviviral activity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted

  14. US 11485709

    Cannabinoid receptor mediating compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted

  15. US 11478542

    Immunogenic RSV polypeptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  16. US 11471443

    Anti-flavivirus compounds and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  17. US 11464801

    Compositions and methods for treating cancer with anti-CD33 immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  18. US 11466071

    HLA class I-restricted t cell receptors against mutated RAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  19. US 11465993

    Water soluble novel cyanine fluorophore with tunable properties between near IR and SWIR region for in vivo imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  20. US 11464845

    Neisseria meningitidis immunogenic compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  21. US 11459320

    Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  22. US 11459360

    Recombinant HIV-1 envelope proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted

  23. US 11453719

    Compositions and methods for treating cancer with anti-ROR1 immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  24. US 11447541

    Anti-coronavirus antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Svcs. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.